136 related articles for article (PubMed ID: 12007506)
41. Tim-3+ T-bet+ tumor-specific Th1 cells colocalize with and inhibit development and growth of murine neoplasms.
Simmons WJ; Koneru M; Mohindru M; Thomas R; Cutro S; Singh P; Dekruyff RH; Inghirami G; Coyle AJ; Kim BS; Ponzio NM
J Immunol; 2005 Feb; 174(3):1405-15. PubMed ID: 15661898
[TBL] [Abstract][Full Text] [Related]
42. In vivo antitumor activity of NKT cells activated by the combination of IL-12 and IL-18.
Baxevanis CN; Gritzapis AD; Papamichail M
J Immunol; 2003 Sep; 171(6):2953-9. PubMed ID: 12960319
[TBL] [Abstract][Full Text] [Related]
43. Inappropriate alloantigen-like specificities detected on reticulum cell sarcomas of SJL/J mice: characterization and biologic role.
Bonavida B; Roman JM; Hutchinson IV
Transplant Proc; 1980 Mar; 12(1):59-64. PubMed ID: 6154360
[TBL] [Abstract][Full Text] [Related]
44. LPS-stimulated SJL macrophages produce IL-12 and IL-18 that inhibit IgE production in vitro by induction of IFN-gamma production from CD3intIL-2R beta+ T cells.
Yoshimoto T; Nagai N; Ohkusu K; Ueda H; Okamura H; Nakanishi K
J Immunol; 1998 Aug; 161(3):1483-92. PubMed ID: 9686615
[TBL] [Abstract][Full Text] [Related]
45. Properties of reticulum cell sarcomas in SJL/J mice. VIII. Prominent role of RCS cell I-A antigens in the stimulation of syngeneic T cells.
Brown PH; Mathis D; Cone RE; Jones PP; Ponzio NM; Thorbecke GJ
Immunogenetics; 1983; 18(4):399-413. PubMed ID: 6226603
[TBL] [Abstract][Full Text] [Related]
46. Properties of reticulum-cell sarcomas in SJL/J mice. I. Proliferative response to tumor cells of T-derived lymphoid cells from normal mice.
Lerman SP; Chapman JM; Carswell EA; Thorbecke GJ
Int J Cancer; 1974 Dec; 14(6):808-16. PubMed ID: 4618550
[TBL] [Abstract][Full Text] [Related]
47. Development of CD8+ effector T cells is differentially regulated by IL-18 and IL-12.
Okamoto I; Kohno K; Tanimoto T; Ikegami H; Kurimoto M
J Immunol; 1999 Mar; 162(6):3202-11. PubMed ID: 10092771
[TBL] [Abstract][Full Text] [Related]
48. Non-H-2-linked control of in vivo growth of SJL/J-derived reticulum cell sarcoma in recombinant inbred strains between BALB/cKe and SJL/J mice.
Sakano T; Wilbur SM; Bonavida B; Cohn M
J Natl Cancer Inst; 1985 Oct; 75(4):669-73. PubMed ID: 3900512
[TBL] [Abstract][Full Text] [Related]
49. Production of cytokines after lipopolysaccharide stimulation of murine spleen cells during lymphoma development in AKR mice.
Vaillier D; Daculsi R; Legrand E; Guillemain B
Cancer Immunol Immunother; 1989; 29(1):35-42. PubMed ID: 2468413
[TBL] [Abstract][Full Text] [Related]
50. Recruitment of natural killer cells in advanced stages of endogenously arising B-cell lymphoma: implications for therapeutic cell transfer.
Przewoznik M; Hömberg N; Naujoks M; Pötzl J; Münchmeier N; Brenner CD; Anz D; Bourquin C; Nelson PJ; Röcken M; Mocikat R
J Immunother; 2012 Apr; 35(3):217-22. PubMed ID: 22421939
[TBL] [Abstract][Full Text] [Related]
51. Interleukin-12 induces cytotoxic NK1+ alpha beta T cells in the lungs of euthymic and athymic mice.
Anzai R; Seki S; Ogasawara K; Hashimoto W; Sugiura K; Sato M; Kumagai K; Takeda K
Immunology; 1996 May; 88(1):82-9. PubMed ID: 8707355
[TBL] [Abstract][Full Text] [Related]
52. Th1 cytokines and NK cells participate in the development of murine syngeneic graft-versus-host disease.
Flanagan DL; Jennings CD; Bryson JS
J Immunol; 1999 Aug; 163(3):1170-7. PubMed ID: 10415011
[TBL] [Abstract][Full Text] [Related]
53. Inhibition of TC-1 cytokine production, effector cytotoxic T lymphocyte development and alloantibody production by 2,3,7,8-tetrachlorodibenzo-p-dioxin.
Kerkvliet NI; Baecher-Steppan L; Shepherd DM; Oughton JA; Vorderstrasse BA; DeKrey GK
J Immunol; 1996 Sep; 157(6):2310-9. PubMed ID: 8805628
[TBL] [Abstract][Full Text] [Related]
54. Natural killer cell activity in reticulum-cell sarcomas of SJL/J mice. III. Characterization of the effector cells within RCS that mediate NK lysis.
Fitzgerald KL; McMaster JS; Ponzio NM
Int J Cancer; 1981 Nov; 28(5):635-45. PubMed ID: 7030971
[No Abstract] [Full Text] [Related]
55. Interleukin-4 is effective in restoring cytotoxic T cell activity that declines during in vivo progression of a murine B lymphoma.
Santra S; Ghosh SK
Cancer Immunol Immunother; 1997 Jul; 44(5):291-300. PubMed ID: 9247564
[TBL] [Abstract][Full Text] [Related]
56. The boosting effect of co-transduction with cytokine genes on cancer vaccine therapy using genetically modified dendritic cells expressing tumor-associated antigen.
Ojima T; Iwahashi M; Nakamura M; Matsuda K; Naka T; Nakamori M; Ueda K; Ishida K; Yamaue H
Int J Oncol; 2006 Apr; 28(4):947-53. PubMed ID: 16525645
[TBL] [Abstract][Full Text] [Related]
57. In vivo growth inhibition of Ia+ lymphomas in SJL mice treated with I-As-reactive monoclonal antibody.
Alisauskas RM; Ponzio NM
Immunopharmacology; 1986 Aug; 12(1):1-9. PubMed ID: 2428770
[TBL] [Abstract][Full Text] [Related]
58. Tumor-induced suppression of interferon-gamma production and enhancement of interleukin-10 production by natural killer (NK) cells: paralleled to CD4+ T cells.
Wei H; Zheng X; Lou D; Zhang L; Zhang R; Sun R; Tian Z
Mol Immunol; 2005 May; 42(9):1023-31. PubMed ID: 15829292
[TBL] [Abstract][Full Text] [Related]
59. Growth of SJL/J-derived RCS as related to its ability to induce T cell proliferation in the host. II. Negative influence of H-2d1.
Katz IR; Chapman-Alexander J; Lerman SP; David CS; Thorbecke GJ
Transplantation; 1982 Feb; 33(2):134-7. PubMed ID: 7036467
[TBL] [Abstract][Full Text] [Related]
60. Mapping of SJL/J reticulum cell sarcoma tumor-associated Ia antigens by T cell hybridomas: characterization of tumor-specific and shared epitopes detected on IE+ allogeneic cells.
Ohnishi K; Bonavida B
J Immunol; 1986 Jul; 137(2):733-40. PubMed ID: 2424977
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
